Navigation Links
DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
Date:1/24/2013

New York, NY (PRWEB) January 24, 2013

The prescription drug resource center DrugRisk.com is alerting women who have used the vaginal ring contraceptive NuvaRing of new information added to the site showing trials are scheduled to begin this year for those claiming they suffered blood clots from the devices.

The mission of DrugRisk is to improve patient safety through education, including the latest drug warnings, recalls, studies and litigation news. “Many patients follow legal news for a drug they’re using to learn if others may be affected with similar problems and whether they have options,” explains DrugRisk representative Ryan Mayer.

DrugRisk contains warnings from experts linking vaginal rings like NuvaRing to higher blood clot risks than traditional birth control pills.

The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives.* On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.** Nevertheless, there has still been no NuvaRing recall.

DrugRisk has also learned that, due to the number of patients filing a NuvaRing lawsuit, cases have been consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Now, new information on the site shows that Judge Rodney Sippel, who is presiding over the federal court, has scheduled trials to begin on July 8, 2013.*** The latest U.S. Judicial Panel on MultiDistrict Litigation update showed NuvaRing lawsuits have risen by nearly 5% to 1076.****

This month, DrugRisk learned of research at Brigham and Women’s Faulkner Hospital which found that, while combined hormone vaginal ring contraceptives like NuvaRing can increase blood clot risks for all women, the risks are significantly higher for those suffering migraines.*****

Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*bmj.com/content/344/bmj.e2990
**nejm.org/doi/full/10.1056/NEJMoa1111840
***Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS
****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-November-2012.pdf
*****foxnews.com/health/2013/01/15/migraines-with-aura-linked-to-heart-disease/

Read the full story at http://www.prweb.com/releases/nuvaring-recall/lawsuit-warnings/prweb10348434.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Announces New Pradaxa Health Warning From Australia
2. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
5. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
6. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
7. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
8. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
9. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
10. Skechers Lawsuit on Behalf an Ohio Woman Who Sustained Serious Ankle Injury Allegedly Due to Shape-Ups' Defective Design Filed by Wright & Schulte LLC
11. New Class Action Lawsuit on Toddler’s Severe Burns from Glass-Fronted Fireplace: Now, AttorneyOne Can Provide Advice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management ... radiology marketing programs at the annual Building Better Radiology Marketing Programs conference, ... Hotel in Fort Worth, Texas. Nine awards are given out in five categories. They ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
(Date:2/23/2017)... 2017  Genesis Healthcare Services has merged with Hospice ... by Bill Monast , President and CEO of ... Nathan Feltman , executives with Home Health Depot, Inc., ... This acquisition helps Hospice Cloud maintain its ... durable medical equipment (DME) solutions for the hospice industry. ...
Breaking Medicine Technology: